| 1 |
Jinarc |
- |
- |
- |
- |
067 [1] 67 💬 |
| 2 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
| 3 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
| 4 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
| 5 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
| 6 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
| 7 |
Jinarc - tolvaptan tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
| 8 |
Jinarc 15 mg tablets, jinarc 45 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
| 9 |
Jinarc 30 mg tablets, 90 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
| 10 |
Jinarc 30 mg tablets, jinarc 60 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
| 11 |
Jinarc® 15mg tablet |
- |
- |
- |
- |
067 [1] 67 💬 |
| 12 |
Jinarc® 30 tablet |
- |
- |
- |
- |
067 [1] 67 💬 |